These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9122126)

  • 21. [Acquired factor XI inhibitor and chronic lymphocytic leukemia].
    Segalen I; Siohan P; Podeur L; Wehbe B; Hutin P; Lellouche F
    Rev Med Interne; 2008 Oct; 29(10):832-3. PubMed ID: 18403064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia and renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2.
    Schlegel PJ; Samlowski WE; Ward JH
    J Immunother; 2000; 23(4):507-8. PubMed ID: 10916762
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma.
    Fodor A; Molnar MZ; Krenacs L; Bagdi E; Csomor J; Matolcsy A; Demeter J
    Pathol Oncol Res; 2009 Dec; 15(4):597-603. PubMed ID: 19343544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia.
    Jung M; Rice L
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S10-3. PubMed ID: 22035737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma.
    Fozza C; Galleu A; Careddu MG; Giannico DB; Bonfigli S; Contini S; Longinotti M
    Ann Hematol; 2010 Jan; 89(1):133-4. PubMed ID: 19578848
    [No Abstract]   [Full Text] [Related]  

  • 26. [An unusual effect of cyclosporine A in a patient with chronic lympholeukemia complicated by autoimmune hemolysis and thrombocytolysis].
    Vinogradova OA; Savchenko VG; Parovichnikova EN; Vakhrusheva TL; Ustinova EN
    Ter Arkh; 1998; 70(7):75-7. PubMed ID: 9742645
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody identification in a patient with chronic lymphocytic leukemia: a case study.
    Wilson JA; Chabot S
    Clin Lab Sci; 2002; 15(3):136-9. PubMed ID: 12778960
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the treatment used in a case of autoimmune hemolytic anemia using the erythrophagocytosis functional test].
    Biondi C; Cotorruelo C; Chernigoy S; Racca A
    Sangre (Barc); 1998 Feb; 43(1):100-1. PubMed ID: 9577196
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological abnormalities in splenic marginal zone cell lymphoma.
    Murakami H; Irisawa H; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Hosomura Y; Kojima M
    Am J Hematol; 1997 Nov; 56(3):173-8. PubMed ID: 9371530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fatal autoimmune hemolytic anemia in a patient with splenic marginal-zone lymphoma with hairy lymphocytes].
    Palomera L; Sola C; Arruga A; Domingo JM; Gutiérrez M
    Rev Clin Esp; 2002 Jun; 202(6):360-1. PubMed ID: 12093409
    [No Abstract]   [Full Text] [Related]  

  • 31. Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature.
    Nader K; Patel M; Ferber A
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):511-3. PubMed ID: 23726016
    [No Abstract]   [Full Text] [Related]  

  • 32. [Autoimmune hemolytic anemia, complement-mediated by warm reactive antibodies, associated with lymphoma].
    Gallurt P; Oyonarte S; Gil JL; Senra A; Millán J
    Rev Clin Esp; 1988 Nov; 183(7):383. PubMed ID: 3062716
    [No Abstract]   [Full Text] [Related]  

  • 33. [Splenomegalic lymphoma].
    Delacrétaz F; Cornu P; Meugé-Moraw C; Baur A
    Rev Med Suisse Romande; 1992 Oct; 112(10):869-73. PubMed ID: 1439434
    [No Abstract]   [Full Text] [Related]  

  • 34. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
    Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
    Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary splenic lymphoma complicated by malignant rheumatoid arthritis and bladder cancer].
    Takai K; Sanada M; Shibuya H
    Rinsho Ketsueki; 1993 Jan; 34(1):79-83. PubMed ID: 8450614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia.
    Morande PE; Borge M; Abreu C; Galletti J; Zanetti SR; Nannini P; Bezares RF; Pantano S; Dighiero G; Oppezzo P; Gamberale R; Giordano M
    Leuk Lymphoma; 2015 Apr; 56(4):1115-22. PubMed ID: 25156469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis.
    Zaucha JM; Hałaburda K; Ciepłuch H; Hellmann A
    Acta Haematol Pol; 1994; 25(2):119-27. PubMed ID: 7915075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible functional asplenia. Autoimmune hemolytic anemia with thrombocytopenia in chronic lymphocytic leukemia.
    Hirano T; Tomiyoshi K; Take H; Watanabe N; Oriuchi N; Inoue T; Naruse M; Endo K
    Clin Nucl Med; 1994 Aug; 19(8):693-5. PubMed ID: 7955748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
    Vick DJ; Byrd JC; Beal CL; Chaffin DJ
    Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.